UK markets open in 5 hours 44 minutes

SELLAS Life Sciences Group, Inc. (SLS)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.4200-0.0600 (-4.05%)
At close: 04:00PM EDT
1.4699 +0.05 (+3.51%)
After hours: 06:46PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Cash flows from operating activities
Net income
-38,778
-37,340
-41,301
-20,699
-16,757
-
Depreciation & amortisation
-
-
-
-
282
0
Deferred income taxes
-
-
0
-239
-23
-95
Stock-based compensation
1,568
2,094
1,726
1,011
578
-
Change in working capital
2,558
3,345
5,641
-7,615
5,872
-
Accounts payable
-418
2,301
1,213
-2,513
-836
-
Other working capital
-28,133
-36,910
-28,309
-26,021
-10,417
-
Other non-cash items
5,641
495
10,161
-4,164
-184
-
Net cash provided by operating activities
-23,633
-31,410
-23,809
-26,021
-10,417
-
Cash flows from investing activities
Investments in property, plant and equipment
-
-5,500
-4,500
-
-
-
Net cash used for investing activities
-
-5,500
-4,500
0
-
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
0
Common stock issued
23,065
22,225
23,994
9,005
29,599
-
Dividends paid
-
-
-
-
-
0
Other financing activities
-
-31
-
-
308
-
Net cash used provided by (used for) financing activities
23,200
22,315
24,079
12,074
38,442
-
Net change in cash
-4,933
-14,595
-4,230
-13,947
28,025
-
Cash at beginning of period
26,381
17,225
21,455
35,402
7,377
-
Cash at end of period
21,448
2,630
17,225
21,455
35,402
-
Free cash flow
Operating cash flow
-23,633
-31,410
-23,809
-26,021
-10,417
-
Capital expenditure
-
-5,500
-4,500
-
-
-
Free cash flow
-28,133
-36,910
-28,309
-26,021
-10,417
-